Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Insulin
Therapeutic Area : Endocrinology
Study Phase : Undisclosed
Sponsor : Novo Nordisk
Deal Size : Undisclosed
Deal Type : Collaboration
Details : The collaboration will focus on the integration of Novo Nordisk's new generation of connected pens, NovoPen® 6 and NovoPen Echo® Plus with DBL-4pen™. Diabeloop is planning a study for Type 2 diabetes to evaluate the efficacy and clinical benefits of ...
Brand Name : Undisclosed
Molecule Type : Peptide
Upfront Cash : Undisclosed
March 21, 2023
Lead Product(s) : Insulin
Therapeutic Area : Endocrinology
Highest Development Status : Undisclosed
Sponsor : Novo Nordisk
Deal Size : Undisclosed
Deal Type : Collaboration
LOOKING FOR A SUPPLIER?